A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in children. According to findings published in Obesity and Endocrinology in January 2025, body mass index (BMI) — the most commonly used tool for assessing weight status — may dramatically overestimate...
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than...
The World Health Organization reports that obesity affects one in eight people globally, making it a major public issue. Yet obesity is not just about diet, exercise, and genes — something else must be afoot. Recently, evidence has pointed to an invisible but powerful culprit: dioxins and dioxin-like polychlorinated diphenyls (DL-PCBs), according to “Association Between...
Recently I was watching a couple of movies from the 1970s; one was a drama filmed in New York City and the other was a documentary filmed in California. There were plenty of random shots of people in streets as well as crowds at various events throughout both. However, one thing about both movies that...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer new possibilities for long-term weight management, according to a recent review article published in Endocrinology. Authors Lauren A. Jones and Daniel I. Brierley, PhD, both of the Centre for Cardiovascular...
Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more...
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...
Fatima Cody Stanford, MD, MPH, MPA, MBA, takes the lessons she learned growing up in Atlanta serving her community and applies them to her work treating obesity. In July, she’ll give the plenary presentation at ENDO 2025, “Changing the Game of Obesity Care Across Lifespan: Policies, Diets, and Drug Innovation,” offering attendees a comprehensive overview...
Recently I was watching a couple of movies from the 1970s; one was a drama filmed in New York City and the other was a documentary filmed in California. There were plenty of random shots of people in streets as well as crowds at various events throughout both. However, one thing about both movies that...
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...
